Acute Effects of Legume-enriched Meals Compared to Western Diet Meals on Postprandial Metabolism in Participants with Increased Cardiometabolic Risk

NCT ID: NCT06270901

Last Updated: 2024-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-02

Study Completion Date

2024-09-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the postprandial effects of legume-enriched meals compared to Western Diet meals on postprandial metabolism. In this context, older adults with increased risk for cardiometabolic diseases consume 4 mixed meals with 36 g or 62 g of protein either designed according to the Planetary Health Diet with legumes as primary protein source or the Western Diet with animal foods as primary protein source, in a randomized order. In a postprandial observation period of 6 hours, parameters of lipid metabolism, glucose and insulin metabolism, amino acid profile, as well as markers of inflammation and vascular function are analysed. Furthermore, neuropsychological parameters and satiety-associated hormones are investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In a randomized crossover design, 30 older men and women with increased risk for cardiometabolic diseases consume 4 mixed meals, which differ in dietary pattern, protein source and protein quantity. Two meals are designed according to the Planetary Health Diet with legumes as primary protein source whereas the other two meals are designed according to the Western Diet with animal food as primary protein source. Two meals are designed as high protein meals (62 g of protein) and two meals are designed as low protein meals (36 g of Protein). Therefore, participants consume 4 different test meals, a Low and a High Protein Western Diet Meal and a Low and a High Protein Planetary Health Diet Meal in a randomized order. During a postprandial observation period of 6 hours, parameters of lipid metabolism (e.g., plasma triglycerides), glucose metabolism (e.g., plasma glucose, serum insulin), as well as markers of inflammation (e.g., IL-6) and vascular function (e.g., pulse wave velocity) are analysed. Furthermore, amino acid profile, neuropsychologic parameters (e.g., appetite) and satiety-associated hormones (e.g., Ghrelin) are investigated. Each intervention will be separated by a washout period of approximately 14 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Protein Planetary Health Diet

High Protein Planetary Health Diet Meal: This meal contains 62 g of protein primarily from plant origin (particularly legumes)

Group Type EXPERIMENTAL

High Protein Planetary Health Diet

Intervention Type OTHER

Planetary Health Diet Meal with 62 g of protein primarily from plant origin

Low Protein Planetary Health Diet

Low Protein Planetary Health Diet Meal: This meal contains 36 g of protein from primarily plant origin (particularly legumes)

Group Type EXPERIMENTAL

Low Protein Planetary Health Diet

Intervention Type OTHER

Planetary Health Diet Meal with 36 g of protein primarily from plant origin

High Protein Western Diet

High Protein Western Diet Meal: This meal contains 62 g of protein primarily form animal origin

Group Type EXPERIMENTAL

High Protein Western Diet

Intervention Type OTHER

Western Diet Meal with 62 g of protein primarily from animal origin

Low Protein Western Diet

Low Protein Western Diet Meal: This meal contains 36 g of protein primarily from animal origin

Group Type EXPERIMENTAL

Low Protein Western Diet

Intervention Type OTHER

Western Diet Meal with 36 g of protein primarily from animal origin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Protein Planetary Health Diet

Planetary Health Diet Meal with 62 g of protein primarily from plant origin

Intervention Type OTHER

Low Protein Planetary Health Diet

Planetary Health Diet Meal with 36 g of protein primarily from plant origin

Intervention Type OTHER

High Protein Western Diet

Western Diet Meal with 62 g of protein primarily from animal origin

Intervention Type OTHER

Low Protein Western Diet

Western Diet Meal with 36 g of protein primarily from animal origin

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* written informed consent
* Non-smoking
* BMI: 27 - 34,9 kg/m2
* Waist circumference (women ≥ 80 cm, men ≥ 94 cm)
* Systolic blood pressure: ≥ 120 mmHg, diastolic blood pressure: ≥ 80 mmHg
* At least one of the following criteria
* Fasting triglycerides in serum: ≥ 150 mg/dL
* Fasting HDL-Cholesterol in serum: women \< 50 mg/dl, men \< 40 mg/dL
* Fasting C-reactive protein in serum: ≥ 2 mg/L
* Fasting glucose in plasma: ≥ 100 mg/dL

Exclusion Criteria

* food intolerances and allergies (especially to legumes)
* Smoking
* malabsorption syndromes
* thyroid diseases
* impaired renal function
* chronic liver disease
* heart failure
* myocardial infarction
* insulin-dependent diabetes mellitus
* chronic inflammatory diseases
* tumors
* anemia
* immunosuppression
* intake of supplements (e.g., fish oil)
* Participation in another study
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal Ministry of Food and Agriculture (BMEL)

UNKNOWN

Sponsor Role collaborator

Federal Office for Agriculture and Food (BLE)

UNKNOWN

Sponsor Role collaborator

University of Bonn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Sarah Egert

Sarah Egert, Prof PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Bonn, Institute of Nutritional and Food Sciences, Nutrition Physiology

Bonn, North Rhine-Westphalia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BMEL: 2822EPS008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mediterranean Diet and Blood Sugar Study
NCT07229781 NOT_YET_RECRUITING NA